0 Ratings

ID

23891

Description

Study part: Adverse Events- Post- Vaccination Observation Booster Dose. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Keywords

  1. 7/16/17 7/16/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 16, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Adverse Events- Post- Vaccination Observation Booster Dose Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

    Adverse Events- Post- Vaccination Observation Booster Dose

    ADVERSE EVENTS – POST–VACCINATION OBSERVATION
    Description

    ADVERSE EVENTS – POST–VACCINATION OBSERVATION

    Alias
    UMLS CUI-1
    C0877248
    Subject number
    Description

    Subject number

    Data type

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
    Description

    Adverse Events

    Data type

    text

    Alias
    UMLS CUI [1]
    C0877248

    Similar models

    Adverse Events- Post- Vaccination Observation Booster Dose

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    ADVERSE EVENTS – POST–VACCINATION OBSERVATION
    C0877248 (UMLS CUI-1)
    Subject number
    Item
    Subject number
    integer
    C2348585 (UMLS CUI [1])
    Item
    Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
    text
    C0877248 (UMLS CUI [1])
    Code List
    Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
    CL Item
    Information not retrievable [U (Information not retrievable [U)
    CL Item
    No Vaccine administered [NA (No Vaccine administered [NA)
    CL Item
    No [N (No [N)
    CL Item
    Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y (Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y)

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial